R. G. Hahn
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Surgery top 10%
- Epidemiology top 10%
- Co-authors
- Allan J. SchuttRichard J. ReitemeierC G MoertelRonald H. BlumCharles G. MoertelD C TormeyD.G. HallerPaul P. Carbone
- Topics
- Cancer Treatment and Pharmacology (9 papers)Colorectal Cancer Treatments and Studies (8 papers)Gastric Cancer Management and Outcomes (6 papers)
- Partner nations
- United States
In The Last Decade
R. G. Hahn
42 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 90
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 643
- Molecular Biology 396
- Surgery 310
- Epidemiology 280
Countries citing papers authored by R. G. Hahn
This map shows the geographic impact of R. G. Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. G. Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. G. Hahn more than expected).
Fields of papers citing papers by R. G. Hahn
This network shows the impact of papers produced by R. G. Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. G. Hahn. The network helps show where R. G. Hahn may publish in the future.
Co-authorship network of co-authors of R. G. Hahn
This figure shows the co-authorship network connecting the top 25 collaborators of R. G. Hahn. A scholar is included among the top collaborators of R. G. Hahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. G. Hahn. R. G. Hahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 144 | |
| 5 | 104 | |
| 6 | 25 | |
| 7 | 78 | |
| 8 | 6 | |
| 9 | 97 | |
| 10 | 24 | |
| 11 | 278 | |
| 12 | 53 | |
| 13 | 62 | |
| 14 | Clinical evaluation of flurbiprofen alone and plus ampicillin in chronic pharyngitis in acute phase. | 4 |
| 15 | 18 | |
| 16 | 4 | |
| 17 | Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer. | 17 |
| 18 | Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer. | 7 |
| 19 | Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. | 231 |
| 20 | Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer. | 36 |
About R. G. Hahn
R. G. Hahn is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 45 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (643 citations) and Pathology and Forensic Medicine (262 citations). R. G. Hahn has collaborated with scholars based in United States. Frequent co-authors include Allan J. Schutt, Richard J. Reitemeier, C G Moertel, Ronald H. Blum, Charles G. Moertel, D C Tormey, D.G. Haller, Paul P. Carbone, Rajesh Ramanathan and David L. Ahmann. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.